Platinum-resistant Recurrent Ovarian Cancer
9 clinical trials · Condition
◉ Watch Platinum-resistant Recurrent Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer (NCT04720807) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2020-09-01 |
| NR in Chemo-induced Peripheral Neuropathy (NCT03642990) | Donna Hammond, PhD | 2019-11-08 |
| An uMbrella Study of BIomarker-driven Targeted Therapy In Patients With Platinum-resistant Recurrent OvariaN Cancer(AMBITION) (NCT03699449) | Yonsei University | 2018-11-26 |
| Apatinib Combined With PLD vs PLD for Platinum-resistant Recurrent Ovarian Cancer (NCT04348032) | Chinese Academy of Medical Sciences | 2018-03-22 |
Track Platinum-resistant Recurrent Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.